Cargando…
The Novel Phosphatase Domain Mutations Q171R and Y65S Switch PTEN from Tumor Suppressor to Oncogene
Phosphatase and tensin homolog deleted on chromosome 10, or PTEN, is a well-characterized tumor suppressor with both lipid and protein phosphatase activities. PTEN is often downregulated by epigenetic mechanisms such as hypermethylation, which leads to constitutive activation of the PI3K–Akt pathway...
Autores principales: | Garrido, Jose Antonio Ma. G., Alcantara, Krizelle Mae M., Danac, Joshua Miguel C., Serrano, Fidel Emmanuel C., Cutiongco-de la Paz, Eva Maria, Garcia, Reynaldo L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700245/ https://www.ncbi.nlm.nih.gov/pubmed/34943931 http://dx.doi.org/10.3390/cells10123423 |
Ejemplares similares
-
Identification and validation of mRNA 3′untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN
por: Roquid, Kenneth Anthony R., et al.
Publicado: (2019) -
MicroRNA-92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells
por: Alcantara, Krizelle Mae M., et al.
Publicado: (2019) -
Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants
por: Alcantara, Krizelle Mae M., et al.
Publicado: (2019) -
CircPVT1 attenuates negative regulation of NRAS by let-7 and drives cancer cells towards oncogenicity
por: Danac, Joshua Miguel C., et al.
Publicado: (2021) -
Phenotypic characterization of the novel, non-hotspot oncogenic KRAS mutants E31D and E63K
por: Angeles, Arlou Kristina J., et al.
Publicado: (2019)